O'Neill Gilmore Neil
SEC insider (Form 3/4/5 filer). CIK 0001742084. CEO at Editas Medicine, Inc. (EDIT). 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in CAMBRIDGE, MA.
Companies O'Neill Gilmore Neil has filed insider reports for
- Editas Medicine, Inc. (EDIT): Director, Officer, CEO
O'Neill Gilmore Neil
CIK: 0001742084
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Editas Medicine, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 3, 2026EDIT
Editas Medicine, Inc.
SaleDirect5.1K shares at avg. $3.04$16K - Jun 3, 2026EDIT
Editas Medicine, Inc.
SaleDirect15.4K shares at avg. $2.70$42K - Mar 12, 2026EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
1M shares- - Mar 3, 2026EDIT
Editas Medicine, Inc.
SaleDirect5.4K shares at avg. $2.02$11K - Dec 3, 2025EDIT
Editas Medicine, Inc.
SaleDirect5.6K shares at avg. $2.15$12K - Sep 3, 2025EDIT
Editas Medicine, Inc.
SaleDirect5.6K shares at avg. $2.60$15K - Jun 3, 2025EDIT
Editas Medicine, Inc.
SaleDirect15.2K shares at avg. $1.72$26K - Mar 8, 2025EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
828K shares- - Mar 8, 2025EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
175K shares- - Mar 4, 2025EDIT
Editas Medicine, Inc.
SaleDirect16.6K shares at avg. $1.71$28K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | EDIT Editas Medicine, Inc. | Sale | 5,124 | $3.04 | $15,563 | Direct |
| Jun 3, 2026 | EDIT Editas Medicine, Inc. | Sale | 15,380 | $2.70 | $41,543 | Direct |
| Mar 12, 2026 | EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 1,015,200 | - | - | Direct |
| Mar 3, 2026 | EDIT Editas Medicine, Inc. | Sale | 5,394 | $2.02 | $10,894 | Direct |
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | Sale | 5,603 | $2.15 | $12,064 | Direct |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | Sale | 5,592 | $2.60 | $14,517 | Direct |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | Sale | 15,192 | $1.72 | $26,196 | Direct |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 828,000 | - | - | Direct |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 175,000 | - | - | Direct |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | Sale | 16,632 | $1.71 | $28,452 | Direct |
1-10 of 12 transactions